Fundz

BOOST Pharma Appoints Hans Schambye as Chief Executive Officer

PRIVATEFeb 10, 2026

Position

Chief Executive Officer

Company

BOOST Pharma

Hans Schambye
BiotechnologyHealth CareTherapeutics

Description

BOOST Pharma has announced the immediate appointment of Hans Schambye, MD, PhD, as its new Chief Executive Officer. This transition occurs as the company advances BT-101, its lead candidate for breaking down barriers in the treatment of Brittle Bone Disease.

Quick answer

BOOST Pharma Appoints Hans Schambye as Chief Executive Officer (February 10, 2026).

Who is the new Chief Executive Officer at BOOST Pharma?
BOOST Pharma named Hans Schambye Chief Executive Officer, announced February 10, 2026.
What did BOOST Pharma announce on February 10, 2026?
BOOST Pharma has announced the immediate appointment of Hans Schambye, MD, PhD, as its new Chief Executive Officer. This transition occurs as the company advances BT-101, its lead candidate for breaking down barriers in the treatment of Brittle Bone Disease.
What does BOOST Pharma do?
BOOST Pharma is based on years of collaborative research from Karolinska Institute in Stockholm with the focus on novel cell therapy treatments for Osteogenesis Imperfecta.
Which similar companies made leadership changes around the same time?
FYR (February 10, 2026), Ocugen (February 9, 2026), Bristol Myers Squibb (February 9, 2026) and Arvinas (February 12, 2026) also announced leadership changes within 45 days of BOOST Pharma.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at BOOST Pharma, and when

A new leader at BOOST Pharma brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day BOOST Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BOOST Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BOOST Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BOOST Pharma

About

BOOST Pharma is based on years of collaborative research from Karolinska Institute in Stockholm with the focus on novel cell therapy treatments for Osteogenesis Imperfecta. The research teams of associate professor Cecilia Götherström and professor Magnus Westgren have shown that that treatment with BOOST Cells greatly enhanced the quality of life for patients suffering from this otherwise extremely debilitating disease.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BOOST Pharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for BOOST Pharma's next move

Learn about Strategic plan

BOOST Pharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.